Pure Global AI
Disease / condition

Unspecified Adult Solid Tumor, Protocol Specific clinical trials

Free access to 355 studies10+ countriesUpdated daily4 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
355
Total trials
10+
Countries
10+
Sponsors
4
Recruiting
By phase
Phase 1299
N/A36
Early Phase 112
Phase 25
Phase 32
By status
Completed294
Terminated26
Unknown19
Withdrawn8
Recruiting4
Top countries
United States of America289
Canada9
United Kingdom9
Austria,Belgium,Denmark,France,Germany,Netherlands,Norway,Switzerland,United Kingdom4
New Zealand,United States of America3
Top sponsors
National Cancer In...77
Memorial Sloan Ket...23
City of Hope Medic...17
Roswell Park Cance...13
Case Comprehensive...12
Recent trials
Latest clinical trials for Unspecified Adult Solid Tumor, Protocol Specific
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Maastricht University
NCT04954599Not yet recr...
Phase
Phase 1/2
A Phase 1 Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid Tumors
Jiangsu HengRui Medicine Co., ... · China
NCT04842630Recruiting
Phase
Phase 1
TR1801-ADC in Patients With Tumors That Express c-Met
Tanabe Research Laboratories U... · United States of America
NCT03859752Not yet recr...
Phase
Phase 1
Communication Training in Promoting Employment Retention Among Cancer Patients
Virginia Commonwealth Universi... · United States of America
NCT02895490Terminated
A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
Nektar Therapeutics · United States of America
NCT02869295Completed
Phase
Early Phase 1
Copenhagen Prospective Personalized Oncology (CoPPO)
Ulrik Lassen · Denmark
NCT02290522Recruiting
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
Stanford University · United States of America
NCT02215928Recruiting
Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy
Sidney Kimmel Cancer Center at... · United States of America
NCT02153151Completed
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors
University of Wisconsin, Madis... · United States of America
NCT02146222Completed
Phase
Phase 1
RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists
City of Hope Medical Center · United States of America
NCT02112565Active, not ...
Phase
Phase 1
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
Jonsson Comprehensive Cancer C... · United States of America
NCT02070406Terminated
Phase
Phase 1
FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents
Case Comprehensive Cancer Cent... · United States of America
NCT02055586Completed
Icotinib Hydrochloride in Treating Patients With Advanced Cancers
Roswell Park Cancer Institute
NCT02033148Withdrawn
Phase
Phase 1
Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors
University of Southern Califor... · United States of America
NCT01957995Completed
Phase
Phase 1
Palliative Care Intervention in Improving Quality of Life, Psychological Distress, and Communication in Patients With Solid Tumors Receiving Treatment
City of Hope Medical Center · United States of America
NCT01828775Completed
Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors
Manisha Shah · United States of America
NCT01713972Completed
Phase
Phase 1
Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies
University of Chicago · United States of America
NCT01705106Terminated
Phase
Phase 1
Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors
University of Southern Califor... · United States of America
NCT01642342Terminated
Phase
Phase 1
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
Proacta, Incorporated · New Zealand,United States of America
NCT01631279Terminated
Phase
Early Phase 1
Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials
City of Hope Medical Center · United States of America
NCT01612598Completed
About this profile

Access comprehensive clinical trial information for Unspecified Adult Solid Tumor, Protocol Specific through Pure Global AI's free database. This collection includes 355 clinical trials across multiple phases including Phase 1, N/A, Early Phase 1. Currently, 4 trials are actively recruiting participants.

Research for Unspecified Adult Solid Tumor, Protocol Specific is being conducted in United States of America, Canada, United Kingdom and 7+ other countries. Leading sponsors include National Cancer Institute (NCI) and Memorial Sloan Kettering Cancer Center. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 355 clinical trials studying Unspecified Adult Solid Tumor, Protocol Specific, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include National Cancer Institute (NCI), Memorial Sloan Kettering Cancer Center, City of Hope Medical Center, among others.